Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Shanghai United Imaging Healthcare Co., Ltd. specializes in advanced medical imaging equipment and healthcare solutions, primarily serving the Chinese market with a growing international presence. The company differentiates itself through its proprietary technology in MRI and CT systems, which enhances diagnostic capabilities and operational efficiency for healthcare providers.
The company generates revenue primarily through the sale of high-tech imaging equipment, leveraging its proprietary technology to command premium pricing. Its strong R&D capabilities allow for continuous innovation, creating a competitive edge in a rapidly evolving market. Additionally, recurring revenue from service contracts enhances stability.
Regulatory approvals for new imaging technologies
Market expansion into Southeast Asia and Europe
Partnerships with hospitals and healthcare providers
Changes in healthcare spending in China
Technological disruption from emerging imaging technologies
Regulatory changes affecting healthcare equipment standards
Intense competition from global players like Siemens and GE Healthcare
Potential market share loss to lower-cost manufacturers
Limited liquidity due to high capital expenditures in R&D
Potential impact of currency fluctuations on international sales
moderate - The company's performance is somewhat linked to GDP growth and healthcare spending, which can fluctuate with economic cycles.
Low - The company has minimal debt, so changes in interest rates do not significantly impact financing costs or valuation multiples.
minimal - The company operates with a low debt-to-equity ratio, reducing reliance on credit markets.
growth - The company shows strong revenue and net income growth, appealing to investors seeking capital appreciation.
moderate - The stock has shown some volatility, particularly with a beta around 1.2, reflecting market sensitivity.